| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |